Evidence map›Paper›PMID 34571822›Full record

ReviewCells2021

Sphingolipids: Effectors and Achilles Heals in Viral Infections?

Sibylle Schneider-Schaulies, Fabian Schumacher, Dominik Wigger, Marie Schöl, Trushnal Waghmare, Jan Schlegel, Jürgen Seibel, Burkhard Kleuser

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Implication of Sphingolipids in Viral Infections.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sibylle Schneider-SchauliesInstitute for Virology and Immunobiology, University of Wuerzburg, 97078 Würzburg, Germany.
Fabian SchumacherInstitute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, 14195 Berlin, Germany.ORCID 0000-0001-8703-3275
Dominik WiggerInstitute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, 14195 Berlin, Germany.
Marie SchölInstitute for Virology and Immunobiology, University of Wuerzburg, 97078 Würzburg, Germany.
Trushnal WaghmareInstitute for Virology and Immunobiology, University of Wuerzburg, 97078 Würzburg, Germany.
Jan SchlegelDepartment for Biotechnology and Biophysics, University of Wuerzburg, 97074 Würzburg, Germany.ORCID 0000-0003-3159-8079
Jürgen SeibelDepartment for Organic Chemistry, University of Wuerzburg, 97074 Würzburg, Germany.ORCID 0000-0002-8036-4853
Burkhard KleuserInstitute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, 14195 Berlin, Germany.
University of Würzburg · DEFreie Universität Berlin · DE

Funding

Deutsche Forschungsgemeinschaft GRK2581
6 · The paper itself

Abstract

As viruses are obligatory intracellular parasites, any step during their life cycle strictly depends on successful interaction with their particular host cells. In particular, their interaction with cellular membranes is of crucial importance for most steps in the viral replication cycle. Such interactions are initiated by uptake of viral particles and subsequent trafficking to intracellular compartments to access their replication compartments which provide a spatially confined environment concentrating viral and cellular components, and subsequently, employ cellular membranes for assembly and exit of viral progeny. The ability of viruses to actively modulate lipid composition such as sphingolipids (SLs) is essential for successful completion of the viral life cycle. In addition to their structural and biophysical properties of cellular membranes, some sphingolipid (SL) species are bioactive and as such, take part in cellular signaling processes involved in regulating viral replication. It is especially due to the progress made in tools to study accumulation and dynamics of SLs, which visualize their compartmentalization and identify interaction partners at a cellular level, as well as the availability of genetic knockout systems, that the role of particular SL species in the viral replication process can be analyzed and, most importantly, be explored as targets for therapeutic intervention.

Indexed as

Virus DiseasesBiological TransportCell MembraneCeramidesDrug Delivery SystemsHIVHost Microbial InteractionsIntracellular MembranesSARS-CoV-2SphingolipidsVirionVirusesVirus ReplicationCeramidesSphingolipidsceramidesglycosphingolipidsHIVmeaslesSARS-CoV-2sphingomyelinasesphingosine 1-phosphate

Identifiers

PMID34571822
PMCPMC8466362
OpenAlexW3195426869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.